Echocardiographic Features of Cardiomyopathy in Emery-Dreifuss Muscular Dystrophy

Table 4

Percentage of EDMD patients meeting the following criteria.

	EDMD1	EDMD2	value
LVEDV >150/106 ml (M/F) (%)	41.4; 12/29	41.7; 5/12	1.00
LVEDVi > 74/61 ml/m2 (M/F) (%)	44.8; 13/29	41.7; 5/12	1.00
LAVi > 34 ml/m2 (%)	48.3; 14/29	58.3; 7/12	0.74
RAVi > 32/27 ml/m2 (M/F) (%)	69.0; 20/29	75.0; 9/12	1.00
RV > 30 mm (%)	6.9; 2/29	25.0; 3/12	0.14
LVEF < 52/54 % (M/F) (%)	41.4; 12/29	41.7; 5/12	1.00
TAPSE < 17 mm (%)	6.9; 2/29	16.7; 2/12	0.57
E/e’ > 14 (%)	16.0; 4/25	16.7; 2/12	1.00
Vprop < 45 cm/s (%)	12.5; 3/24	33.3; 4/12	0.19

E/e’: mitral early peak velocity/annular velocity; LAVi: left atrial volume index; LVEDV: left ventricular end-diastolic volume; LVEDVi: left ventricular end-diastolic volume index; LVEF: left ventricular ejection fraction; RAVi: right atrial volume index; RV: right ventricle; TAPSE: tricuspid annular plane systolic excursion; Vprop: inflow propagation velocity.